title: DHAP treatment: results of 18 patients with refractory or recurrent non Hodgkin's lymphoma.
authors.forename: M
authors.initials: M
authors.lastname: Martelli
authors.forename: G
authors.initials: G
authors.lastname: Cimino
authors.forename: R
authors.initials: R
authors.lastname: Gastaldi
authors.forename: L
authors.initials: L
authors.lastname: Mantovani
authors.forename: C
authors.initials: C
authors.lastname: Sgadari
authors.forename: S
authors.initials: S
authors.lastname: Amadori
authors.forename: C
authors.initials: C
authors.lastname: Guglielmi
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008875:Middle Aged; D012008:Recurrence
chemical_list: D003561:Cytarabine; D003907:Dexamethasone; D002945:Cisplatin